CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-13 | DUGAN RICHARD W Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-06-13 | MILANO VINCENT Director | Grant or award | +5,000 | 10,000 | ||
| 2018-06-13 | MILANO VINCENT Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-06-13 | Watkins Thomas Director | Grant or award | +5,000 | 25,000 | ||
| 2018-06-13 | Watkins Thomas Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-05-03 | Watkins Thomas Director | Option exercise | +15,000 | $4.98 | $75K | 20,000 |
| 2018-05-03 | Watkins Thomas Director | Option exercise · Stock Option (Right to Buy) | +15,000 | 0 | ||
| 2018-03-19 | DUGAN RICHARD W Director | Option exercise | +15,000 | $4.98 | $75K | 25,770 |
| 2018-03-19 | DUGAN RICHARD W Director | Option exercise · Employee Stock Option (Right to Buy) | +15,000 | 0 | ||
| 2018-03-01 | Polymeropoulos Mihael Hristos President and CEO | Sale | −60,966 | $18.72 | $1.1M | 1,182,872 |
| 2018-03-01 | Kelly James Patrick EVP & Chief Financial Officer | Sale | −8,532 | $18.72 | $160K | 199,534 |
| 2018-03-01 | Gulino Richard L. SVP, General Counsel & Sec. | Sale | −3,660 | $18.71 | $68K | 115,073 |
| 2018-03-01 | Birznieks Gunther SVP, Business Development | Sale | −8,525 | $18.72 | $160K | 139,841 |
| 2018-02-28 | Reverberi Gian Piero SVP & Chief Commercial Officer | Grant or award | +30,000 | 140,000 | ||
| 2018-02-28 | Reverberi Gian Piero SVP & Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2018-02-28 | Polymeropoulos Mihael Hristos President and CEO | Grant or award | +60,000 | 1,243,838 | ||
| 2018-02-28 | Polymeropoulos Mihael Hristos President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2018-02-28 | Kelly James Patrick EVP & Chief Financial Officer | Grant or award | +40,000 | 208,066 | ||
| 2018-02-28 | Kelly James Patrick EVP & Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2018-02-28 | Gulino Richard L. SVP, General Counsel & Sec. | Grant or award | +30,000 | 118,733 |
Page 19 of 20 · 387 trades